Abstract
Statins are among the most widely prescribed drugs. An increasing number of lupus-like syndrome has recently been reported with these lipid-lowering agents. We describe a new case associated with simvastatin therapy. The presence of anti-dsDNA antibodies in the serum is for the first time reported confirming that statins may also induce a systemic autoimmune reaction. Statin-induced lupus-like syndrome is characterized by the long delay between the beginning of therapy and the skin eruption. Antinuclear antibodies may persist for many months after drug discontinuation. The causal relationship may be therefore difficult to establish, and probably many cases are unrecognized. Early diagnosis may avoid unnecessary immunosuppressive therapy.
References
1.
Hanson J, Bossingham D: Lupus-like syndrome associated with simvastatin. Lancet 1998;352:1070.
2.
Srivastava M, Rencic A, Diglio G, et al: Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol 2003;139:45–49.
3.
Noël B, Cerottini JP, Panizzon RG: Atorvastatin-induced dermatomyositis. Am J Med 2001;110:670–671.
4.
Sridhar MK, Abdulla A: Fatal lupus-like syndrome and ARDS induced by fluvastatin. Lancet 1998;352:114.
5.
Mok CC, Lau CS: Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003;56:481–490.
6.
Mevorach D: Systemic lupus erythematosus and apoptosis: A question of balance. Clin Rev Allergy Immunol 2003;25:49–60.
7.
Baima B, Sticherling M: Apoptosis in different cutaneous manifestations of lupus erythematosus. Br J Dermatol 2001;144:958–966.
8.
Rovere P, Sabbadini MG, Fazzini F, et al: Remnants of suicidal cells fostering systemic autoaggression: Apoptosis in the origin and maintenance of autoimmunity. Arthritis Rheum 2000;43:1663–1672.
9.
Knapp AC, Huang J, Starling G, et al: Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death. Atherosclerosis 2000;152:217–227.
10.
Chapman-Shimshoni D, Yuklea M, Radnay J, et al: Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9. Exp Hematol 2003;31:779–783.
11.
Trebeden-Negre H, Weill B, Fournier C, et al: B cell apoptosis accelerates the onset of murine lupus. Eur J Immunol 2003;33:1603–1612.
12.
Vial T, Nicolas B, Descotes J: Drug-induced autoimmunity: Experience of the French pharmacovigilance system. Toxicology 1997;119:23–27.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
